Main Uses and Benefits of Revolution for Dogs

Revolution for Dogs is a topical parasiticidal product designed to address several internal and external parasites commonly found in canines. Its primary active ingredient, selamectin, works by interfering with the nervous system of specific pests, leading to their elimination and preventing further infestation.

Prevention of Heartworm Disease

One of the primary applications of this medication is the prevention of heartworm disease. Heartworms are transmitted through mosquito bites; once inside the dog, they develop into adults that reside in the heart and pulmonary arteries. The medication acts by eliminating the tissue stages of heartworm larvae, preventing them from maturing into adult worms.

Flea Control and Management

Revolution is utilized to treat and prevent flea infestations. It targets both adult fleas on the dog's body and prevents flea eggs from hatching. By interrupting the flea life cycle, the medication helps reduce the population of fleas in the animal's environment and provides relief from flea-associated irritation.

Treatment of Ear Mites

Ear mites are microscopic parasites that can cause significant discomfort, inflammation, and secondary infections in a dog's ear canals. The medication is effective in eliminating these infestations, helping to restore ear health and prevent the spread of mites to other animals.

Addressing Sarcoptic Mange

Sarcoptic mange is a skin condition caused by burrowing mites that lead to intense itching, hair loss, and skin crusting. Revolution is used to treat and control these infestations, aiding in the resolution of skin lesions and improving the overall dermatological health of the dog.

Tick Control

In addition to other parasites, the medication is indicated for the treatment and control of specific tick species, such as the American Dog Tick. Controlling tick populations is a key aspect of canine healthcare, as these parasites are known vectors for various pathogens.

Comprehensive Parasite Protection

The benefit of using this type of treatment lies in its broad-spectrum activity. By addressing multiple types of parasites—both internal and external—with a single application, it simplifies the management of canine parasitic health and contributes to the long-term well-being of the animal.

Regulatory References

1. DailyMed NLM on Selamectin

The eligibility profile for Revolution (Selamectin) for dogs is strictly defined by regulatory documents based on the animal's age, health status, and prior disease management.

Populations and Contraindications

The product is formally approved for use in dogs six weeks of age and older. Use is contraindicated in any puppy younger than six weeks. Furthermore, the official prescribing information prohibits administration to animals that are sick, debilitated, or severely underweight. This restriction establishes a clear exclusion for dogs with poor systemic health or significant frailty.

Conditional Use and Reproductive Status

Conditional use applies to heartworm status: dogs must be tested for existing heartworm infections prior to starting the medication. If a dog tests positive, treatment to remove adult heartworms is required before initiating the product for prevention. In contrast, the product’s use is permitted in breeding males and females, and safety has been established for use throughout both pregnancy and lactation.

Interactions with other medicines and products

Revolution (selamectin) is a macrocyclic lactone compound used as a topical solution for parasite prevention and control in dogs. According to official regulatory documents (EMA Summary of Product Characteristics), no interactions with other medicinal products or other forms of interaction are known for this product.

Interaction scope

Classification	Detail (Based on Regulatory Documents)
Medicinal product categories with documented interactions	None known
Specific interacting medicines (if explicitly listed)	None explicitly listed
Mechanistic basis of interactions (only if stated in label)	None stated
Interaction-related restrictions	None stated

Interaction classifications (high-level)

Classification	Detail (Based on Official Regulatory Documents)
Interaction severity classification	Not classified (as no interactions are known)
Regulatory basis	EMA Summary of Product Characteristics (SPC)

Official interaction statements

• Interaction with other medicinal products and other forms of interaction: None known.

This interaction profile indicates that, based on official regulatory assessments of the product, there are no documented clinical or pharmacological concerns requiring specific restrictions or precautions regarding the concurrent administration of other medicines. The official labeling specifies a lack of known interactions, thus defining a clean interaction structure for the product.

The action of Selamectin is defined by its mechanism, which features high target specificity and biological selectivity relative to the canine host.

Targeting Invertebrate Chloride Channels

The primary mechanism involves sustained agonism at the glutamate-gated chloride channels ( GluCl), which are ion channels found in the nerve and muscle cells of target invertebrate organisms. By binding to these channels, Selamectin forces a continuous, massive influx of chloride ions ( Cl^-) into the cell. This rapid chemical change induces profound hyperpolarization—a state of electrical over-inhibition that results in the suppression of nerve signal transmission and muscle contraction.

Cascade to Flaccid Paralysis and Elimination

The cellular hyperpolarization triggers an irreversible neuromuscular blockade, resulting in flaccid paralysis across the parasite's entire body. The sustained functional shutdown maintains the neuromuscular blockade, leading to the physical elimination of the organism. The mechanistic selectivity for the canine host is supported because the host lacks the highly sensitive GluCl targets and possesses an active P-glycoprotein ( P-gp) efflux pump that actively minimizes drug access to the central nervous system.

How to Use Revolution for Dogs: Administration Guidelines

Instructions for Revolution (Selamectin) are centered on a topical delivery system and a strict schedule.

---

Administration Scope

Feature	Instruction
Route of administration	Topical (Dermal) application via the ready-to-use spot-on solution.
Dosing schedule	Minimum dose of 6 mg/kg (2.7 mg/lb) of selamectin. The entire contents of the appropriate single-dose tube(s) must be administered.
Timing in relation to meals (if applicable)	Not applicable; administration is dermal, not oral.
Preparation requirements (if applicable)	None; the product is a ready-to-use liquid solution.
Age-group administration rules	Restricted for use only in dogs that are six weeks of age and older.
Missed-dose rules	If a monthly interval is exceeded, immediate administration is required, followed by a resumption of the standard monthly schedule.
Special procedural conditions	For dogs over 130 lbs, an appropriate combination of tubes is necessary to meet the minimum dose. Do not apply when the haircoat is wet or to broken skin.

---

Instruction Classifications (High-Level)

Classification	Detail
Administration method type	Topical (Dermal)
Frequency pattern	Monthly intervals (every 30 days)
Use-context constraints	Must be applied to dry, intact skin only.

---

Resulting Procedural Structure

Step sequence (Topical Application):

• Select the correct single-dose tube based on the dog’s weight.
• Part the hair at the base of the neck in front of the shoulder blades until the skin is visible.
• Place the tube tip directly onto the skin and squeeze to dispense the entire contents in one spot.
• Do not massage the product into the skin.

Connection to the overall use protocol:

These instructions define the procedure for Revolution, utilizing the dermal route and a weight-based dose to ensure proper systemic delivery. The rules establish a fixed monthly schedule and specific application conditions, such as applying to dry, intact skin, to maintain the product's effectiveness.

Research Evidence / Overview of Studies for Revolution for Dogs

Evidence for Patterns Related to Avoidance of Heartworm Development

Research examining the use of Selamectin was conducted to assess patterns related to avoidance of heartworm development and included controlled laboratory studies and randomized field trials, which informed the regulatory evidence. The research focused on dogs confirmed to be free of existing adult heartworm infections. Researchers monitored outcomes such as the absence of microfilariae and heartworm antigens at various checkpoints throughout the study period. Findings described patterns related to the absence of the parasite when the compound was observed under conditions of monthly administration.

Evidence for Patterns Related to Avoidance of Flea Development

The body of evidence for patterns related to avoidance of flea development includes short-term randomized controlled trials (RCTs) and clinical field studies used in research exploring how symptoms change over time related to infestations. These studies monitored outcomes linked to inflammatory or irritative states, such as flea count measurements and changes in clinical signs like pruritus (itching) and dermal irritation. Consistent monthly observation periods were monitored to describe the duration of antiparasitic activity. Evidence remains limited regarding outcomes related to sustained long-term symptom patterns like pruritus beyond the typical 30-to-90-day study window.

Research Exploring Patterns in Mites and Ticks

Research has explored the use of Selamectin for managing ear mites (Otodectes cynotis) and sarcoptic mange (Sarcoptes scabiei), primarily through clinical field studies. Specific measured outcomes included measurements of mite counts following one or two doses, including whether mite absence was observed. Similar studies also focused on the reduction rates for the American dog tick (Dermacentor variabilis).

Areas of Research Uncertainty and Study Gaps

The available evidence quality varies across studies, and findings primarily describe group patterns, not personal outcomes. Research highlights what is known, but long-term patterns may not be fully established beyond the typical follow-up durations used for initial regulatory assessment. Data for specific subgroups of dogs, such as those with certain comorbidities, remain insufficient.

Key Studies & References

1. Selamectin solution (DailyMed Labeling - Detailed Indications, Dosing, and Clinical Field Study Results for Dogs and Cats)
2. SelaSpot (selamectin) - Animal Drugs @ FDA (Regulatory Labeling Document for Dogs and Cats)
3. Evaluation of the effects of selamectin against adult and immature stages of fleas (Ctenocephalides felis felis) on dogs and cats (Original Flea Efficacy Study)

Common questions about Revolution for Dogs (FAQ)

Q: What is selamectin?

Selamectin is classified as a macrocyclic lactone compound. In veterinary contexts, it is used for the management of certain parasitic infestations in animals.

---

Q: How does Revolution for Dogs work to address parasites?

Revolution for Dogs, which contains the active ingredient selamectin, works by affecting the nervous systems of susceptible invertebrates. This action can lead to the death of various parasites, including fleas, certain ticks, and mites, in the treated animal.

---

Q: What parasites is Revolution for Dogs generally indicated for?

The regulatory indications for Revolution for Dogs typically include the prevention of heartworm disease and the control of adult fleas. It is also indicated for the treatment and control of ear mites and sarcoptic mange in dogs.

---

Q: Is Revolution for Dogs considered an effective treatment?

Clinical studies have observed a positive effect on the reduction or elimination of the indicated parasites in treated animals when administered as directed by a veterinarian. Regulatory approval signifies that the product's benefits outweigh the risks for the intended use.

---

Q: Are there any known side effects or adverse reactions associated with Revolution for Dogs?

As with any veterinary medication, some dogs may experience adverse reactions. The most commonly reported events have included transient signs at the application site, such as temporary hair loss or inflammation. Vomiting or diarrhea has been observed in a small number of cases. A veterinarian should be consulted for a full review of potential risks.

Storage and Disposal Requirements for Revolution (Selamectin)

Revolution (selamectin) topical solution must be stored according to regulatory requirements to ensure stability and safety, as the product is flammable.

---

Storage Conditions

• Temperature and Safety: Store at or below 30 C (86 F). The product must be stored away from heat, sparks, open flames, or any source of ignition.
• Protection: Keep the medication in its original, tightly closed container and protect from direct sunlight.
• Child Safety: It is mandatory to keep out of the reach of children.

---

Disposal Instructions

The product is intended for single use. Empty tubes should be disposed of in ordinary household refuse (trash). The unused solution is an environmental hazard; it is strictly required to avoid release to the environment and must not be placed down any drain or waterway.